Sappiens
SAPPIENS is aiming to develop a 1st neuroprotective treatment in parkinson disease and beyond. SAPPIENS is a neuroprotective flagship program based on CXS003 molecule treatment. The company filed patents covering 6 diseases and is finalizing the series A investment round for CXS003 neuro-protective treatment, created to stop the progression of neurological disorders and Parkinson’s.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Sappiens
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Sappiens
1 distinct titles indexed · top 1 shown.
- 1finance & research
Sign up to unlock all 2 contacts at Sappiens
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Sappiens
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.